Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy

BACKGROUND AND AIMS: The standard palliative chemotherapy for pancreatic ductal adenocarcinoma (PDAC) is gemcitabine-based chemotherapy; however, PDAC still presents a major therapeutic challenge. The aims of this study were to investigate the expression pattern of genes involved in gemcitabine sens...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Neoplasia: An International Journal for Oncology Research
المؤلفون الرئيسيون:	Hayato Fujita, Kenoki Ohuchida, Kazuhiro Mizumoto, Soichi Itaba, Tetsuhide Ito, Kohei Nakata, Jun Yu, Tadashi Kayashima, Ryota Souzaki, Tatsuro Tajiri, Tatsuya Manabe, Takao Ohtsuka, Masao Tanaka
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2010-10-01
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S147655861080048X